Development of New Target Stations for the South African Isotope Facility
iThemba LABS, National Research Foundation, Old Faure Road, Somerset West 7129, South Africa
*
Author to whom correspondence should be addressed.
Instruments 2018, 2(4), 29; https://doi.org/10.3390/instruments2040029
Received: 9 November 2018 / Revised: 4 December 2018 / Accepted: 6 December 2018 / Published: 10 December 2018
(This article belongs to the Special Issue Instruments and Methods for Cyclotron Produced Radioisotopes)
The development of new target stations for radioisotope production based on a dedicated 70 MeV commercial cyclotron (for protons) is described. Currently known as the South African Isotope Facility (SAIF), this initiative will free the existing separated-sector cyclotron (SSC) at iThemba LABS (near Cape Town) to mainly pursue research activities in nuclear physics and radiobiology. It is foreseen that the completed SAIF facility will realize a three-fold increase in radioisotope production capacity compared to the current programme based on the SSC.
View Full-Text
Keywords:
radionuclide production; target stations; targetry; 70 MeV cyclotron
▼
Show Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Steyn, G.F.; Anthony, L.S.; Azaiez, F.; Baard, S.; Bark, R.A.; Barnard, A.H.; Beukes, P.; Broodryk, J.I.; Conradie, J.L.; Cornell, J.C.; De Villiers, J.G.; Dolley, S.G.; Du Plessis, H.; Duckitt, W.D.; Fourie, D.T.; Hogan, M.E.; Kohler, I.H.; Lawrie, J.J.; Lussi, C.; Mira, J.P.; Mjali, K.V.; Mostert, H.W.; Naidoo, C.; Nemulodi, F.; Saal, D.; Stodart, N.P.; Thomae, R.W.; Van Niekerk, J.; Van Schalkwyk, P.A. Development of New Target Stations for the South African Isotope Facility. Instruments 2018, 2, 29.
Show more citation formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.